{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:26:26Z","timestamp":1787167586919,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.arcmed.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T18:46:48Z","timestamp":1496342808000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["RAS Genetic Variants in Interaction with ACE Inhibitors Drugs Influences Essential Hypertension Control"],"prefix":"10.1016","volume":"48","author":[{"given":"Farzad","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Zubaidah","family":"Mohd Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patimah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Arkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2017.03.003_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10557-014-6537-6","article-title":"Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?","volume":"28","author":"Schilders","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.arcmed.2017.03.003_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4297\/najms.2011.3540","article-title":"Prevalence, awareness and control of hypertension in estate workers in Malaysia","volume":"3","author":"Annamalai","year":"2011","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.arcmed.2017.03.003_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/pgs.10.34","article-title":"Pharmacogenomics of antihypertensive drugs: past, present and future","volume":"1","author":"Johnson","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.arcmed.2017.03.003_bib4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/pgs.09.61","article-title":"Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance","volume":"10","author":"Arnett","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.arcmed.2017.03.003_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11906-011-0212-0","article-title":"Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System\u2013Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System","volume":"13","author":"Konoshita","year":"2011","journal-title":"Curr Hypertens Reports"},{"key":"10.1016\/j.arcmed.2017.03.003_bib6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCGENETICS.112.964080","article-title":"Hypertension Susceptibility Loci and Blood Pressure Response to Antihypertensives-Results from the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study","volume":"5","author":"Gong","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.arcmed.2017.03.003_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/17425250903571670","article-title":"Genetic polymorphisms related to the renin\u2013angiotensin\u2013aldosterone system and response to antihypertensive drugs","volume":"6","author":"Taverne","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.arcmed.2017.03.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-8-11","article-title":"Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects","volume":"8","author":"Ramachandran","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.arcmed.2017.03.003_bib9","doi-asserted-by":"crossref","first-page":"e001521","DOI":"10.1161\/JAHA.114.001521","article-title":"Pharmacogenomics of Hypertension: A Genome-Wide, Placebo-Controlled Cross-Over Study, Using Four Classes of Antihypertensive Drugs","volume":"4","author":"Hiltunen","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.arcmed.2017.03.003_bib10","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3109\/07853890.2011.653399","article-title":"Advancing management of hypertension through pharmacogenomics","volume":"44","author":"Johnson","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.arcmed.2017.03.003_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/hr.2012.43","article-title":"Reevaluation of the association of seven candidate genes with blood pressure and hypertension: a replication study and meta-analysis with a larger sample size","volume":"35","author":"Takeuchi","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.arcmed.2017.03.003_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/1470320314538878","article-title":"Association of insertion\/deletion polymorphism of angiotensin-converting enzyme gene among Malay male hypertensive subjects in response to ACE inhibitors","volume":"16","author":"Heidari","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.arcmed.2017.03.003_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI117083","article-title":"Angiotensinogen as a risk factor for essential hypertension in Japan","volume":"93","author":"Hata","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2017.03.003_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1006\/bbrc.1993.2554","article-title":"Cross-sectional analysis of Met 235\u2192 Thr variant of angiotensinogen gene in severe, familial hypertension","volume":"197","author":"Bennett","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"10.1016\/j.arcmed.2017.03.003_bib15","first-page":"294","article-title":"The M235T polymorphism in the angiotensinogen gene and myocardial infarction risk: A meta-analysis","volume":"2014","author":"Wang","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.arcmed.2017.03.003_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1161\/CIRCULATIONAHA.106.642058","article-title":"Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor","volume":"115","author":"Su","year":"2007","journal-title":"Circ"},{"key":"10.1016\/j.arcmed.2017.03.003_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.tpj.6500280","article-title":"Renin\u2013angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients","volume":"5","author":"Redon","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.arcmed.2017.03.003_bib18","first-page":"1602","article-title":"Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition","volume":"13","author":"Hingorani","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.arcmed.2017.03.003_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2125.1995.tb04419.x","article-title":"Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects","volume":"39","author":"Todd","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.arcmed.2017.03.003_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0895-7061(97)00279-3","article-title":"Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension","volume":"10","author":"Nakano","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2017.03.003_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000025845","article-title":"Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease","volume":"21","author":"Haas","year":"1998","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.arcmed.2017.03.003_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0895-7061(97)00402-0","article-title":"Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension","volume":"11","author":"Mondorf","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2017.03.003_bib23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/00005344-199812000-00017","article-title":"Effect of the insertion\/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure","volume":"32","author":"O'Toole","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.arcmed.2017.03.003_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1007820401377","article-title":"Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism","volume":"14","author":"Stavroulakis","year":"2000","journal-title":"Cardiovascu Drugs Ther"},{"key":"10.1016\/j.arcmed.2017.03.003_bib25","series-title":"Transplant proc","first-page":"1763","article-title":"Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition","volume":"34","author":"Suwelack","year":"2002"},{"key":"10.1016\/j.arcmed.2017.03.003_bib26","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.amjhyper.2003.07.018","article-title":"Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients","volume":"16","author":"Bis","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.arcmed.2017.03.003_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.HYP.0000088322.85804.96","article-title":"The ACE gene I\/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition","volume":"42","author":"Harrap","year":"2003","journal-title":"J Hypertension"},{"key":"10.1016\/j.arcmed.2017.03.003_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107424840300800i105","article-title":"Correlation of angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by angiotensin-converting enzyme inhibitor","volume":"8","author":"Li","year":"2003","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2017.03.003_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3317\/jraas.2004.029","article-title":"Vascular effects of quinapril completely depend on ACE insertion\/deletion polymorphism","volume":"5","author":"Voors","year":"2004","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.arcmed.2017.03.003_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/HCO.0b013e3283007ba6","article-title":"Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy","volume":"23","author":"Brugts","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.arcmed.2017.03.003_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s10038-004-0149-0","article-title":"D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients","volume":"49","author":"Zhang","year":"2004","journal-title":"J Hum Genet"},{"key":"10.1016\/j.arcmed.2017.03.003_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2017.03.003_bib33","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1161\/01.CIR.90.5.2199","article-title":"Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese","volume":"90","author":"Nakai","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2017.03.003_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0961203311418268","article-title":"Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus","volume":"21","author":"Abbas","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.arcmed.2017.03.003_bib35","article-title":"Gender specific association of RAS gene polymorphism with essential hypertension: a case-control study","author":"Singh","year":"2014","journal-title":"Bio Med Res Int"},{"key":"10.1016\/j.arcmed.2017.03.003_bib36","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/HJH.0000000000000204","article-title":"Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT","volume":"32","author":"Reisin","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.arcmed.2017.03.003_bib37","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1291\/hypres.26.881","article-title":"Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients","volume":"26","author":"Yu","year":"2003","journal-title":"Hypertens Res"},{"key":"10.1016\/j.arcmed.2017.03.003_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/1470320312444650","article-title":"Estimation of risk and interaction of single nucleotide polymorphisms at angiotensinogen locus causing susceptibility to essential hypertension: a case control study","volume":"13","author":"Charita","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.arcmed.2017.03.003_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1254\/jphs.12R03CR","article-title":"Renin\u2013angiotensin system, hypertension, and chronic kidney disease: pharmacogenetic implications","volume":"120","author":"Santos","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.arcmed.2017.03.003_bib40","series-title":"Association between renin\u2013angiotensin\u2013aldosterone system-related genes and blood pressure in a Korean population","first-page":"204","volume":"20","author":"Song","year":"2011"},{"key":"10.1016\/j.arcmed.2017.03.003_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/HJH.0b013e328341d117","article-title":"A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals","volume":"29","author":"Brugts","year":"2011","journal-title":"J Hypertens"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440917300541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440917300541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:45:14Z","timestamp":1759261514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440917300541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0188440917300541"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2017.03.003","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RAS Genetic Variants in Interaction with ACE Inhibitors Drugs Influences Essential Hypertension Control","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}